Docusign (NASDAQ:DOCU) CRO Sells $402,300.00 in Stock

Docusign Inc. (NASDAQ:DOCUGet Free Report) CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the transaction, the executive directly owned 68,970 shares of the company’s stock, valued at $4,624,438.50. This trade represents a 8.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Docusign Stock Up 1.3%

Shares of Docusign stock traded up $0.85 during trading on Tuesday, reaching $65.19. The company’s stock had a trading volume of 3,173,913 shares, compared to its average volume of 3,258,453. The company has a 50-day simple moving average of $68.54 and a two-hundred day simple moving average of $73.02. Docusign Inc. has a 1-year low of $63.41 and a 1-year high of $99.30. The company has a market cap of $13.06 billion, a price-to-earnings ratio of 45.59, a P/E/G ratio of 3.20 and a beta of 0.99.

Institutional Investors Weigh In On Docusign

Large investors have recently bought and sold shares of the company. Ancora Advisors LLC increased its position in shares of Docusign by 90.9% during the first quarter. Ancora Advisors LLC now owns 735 shares of the company’s stock worth $60,000 after purchasing an additional 350 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Docusign by 36.4% in the first quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock valued at $749,000 after buying an additional 2,457 shares during the last quarter. Fred Alger Management LLC purchased a new position in shares of Docusign in the first quarter worth about $256,000. Caxton Associates LLP acquired a new position in Docusign during the first quarter worth about $738,000. Finally, Empowered Funds LLC grew its stake in Docusign by 270.1% during the 1st quarter. Empowered Funds LLC now owns 104,485 shares of the company’s stock valued at $8,505,000 after acquiring an additional 76,255 shares in the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DOCU shares. Bank of America dropped their price objective on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research report on Wednesday, December 17th. Evercore ISI reduced their price target on Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a report on Friday, December 5th. Cantor Fitzgerald reissued an “outperform” rating on shares of Docusign in a report on Wednesday, December 17th. Finally, Wall Street Zen raised Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Six analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $85.13.

View Our Latest Analysis on Docusign

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.